China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time ...

Then, a company named Regeneron announced they would buy the company, and would “prioritize [consumer data's] privacy, ...

Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

Biogen has emerged as a potential front-runner at the Cannes Lions International Festival of Creativity, snagging four spots ...

Texas Attorney General Ken Paxton is looking to protect Texans' genetic data with action filed this week in ongoing 23andMe ...

Me, which became a household name for its genetic testing services, is set to emerge from bankruptcy as a nonprofit.

SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered ...

But what about the other end of the spectrum? Let's take a quick look at the two worst performers on the Nasdaq-100 in May 2025.

If you like what we do here, forward this email to a friend. They can get this newsletter every week through a STAT+ ...

Utah Attorney General Derek Brown has joined 27 other states in a lawsuit against genealogy company 23andMe and its recently proposed sale of customer data.

Avanza Fonder AB reduced its holdings in Regeneron Pharmaceuticals by 14.5% in the first quarter, still maintaining $5.57 million in shares. Several heavyweight institutional investors continued to ...